MGMT and glioma: However, the obstacles in glioma therapy include acquired resistance to TMZ-mediated DNA damage via the function of DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT), incomplete surgical resection due to the highly aggressive behavior of glioma and glioma stem cells, and tumor-supportive microenvironment4–6.